Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.650
+0.150 (4.29%)
At close: Mar 9, 2026, 4:00 PM EDT
3.670
+0.020 (0.55%)
After-hours: Mar 9, 2026, 7:56 PM EDT
Ironwood Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 24.02 | 0.88 | -1,002 | 175.07 | 528.45 | |
| Depreciation & Amortization | 1.88 | 2.01 | 1.58 | 1.42 | 1.52 | |
| Loss (Gain) From Sale of Assets | 0.09 | 0.08 | - | 0 | 0.09 | |
| Asset Writedown & Restructuring Costs | - | - | 1,095 | - | - | |
| Stock-Based Compensation | 17.25 | 29.85 | 32.01 | 27.05 | 22.28 | |
| Other Operating Activities | 44.16 | 71.55 | 45.36 | 67.41 | -308.18 | |
| Change in Accounts Receivable | 35.15 | 47.24 | 0.92 | 7.99 | 7.71 | |
| Change in Accounts Payable | 6.2 | -20.21 | 12.38 | -8.12 | -2.64 | |
| Change in Other Net Operating Assets | -1.7 | -27.85 | -2.03 | 2.94 | 12.66 | |
| Operating Cash Flow | 127.04 | 103.55 | 183.43 | 273.76 | 261.9 | |
| Operating Cash Flow Growth | 22.69% | -43.55% | -33.00% | 4.53% | 55.12% | |
| Capital Expenditures | -0.03 | -0.14 | -0.27 | -0.14 | -0.27 | |
| Cash Acquisitions | - | - | -1,026 | - | - | |
| Investing Cash Flow | -0.03 | -0.14 | -1,026 | -0.14 | -0.27 | |
| Long-Term Debt Issued | - | 150 | 400 | - | - | |
| Long-Term Debt Repaid | - | -265 | -100 | -120.7 | - | |
| Net Debt Issued (Repaid) | - | -115 | 300 | -120.7 | - | |
| Issuance of Common Stock | 0.22 | 11.01 | 6.36 | 9.54 | 19.58 | |
| Repurchase of Common Stock | - | -0.74 | - | -126.39 | -24.13 | |
| Other Financing Activities | - | -2.25 | -29.2 | - | - | |
| Financing Cash Flow | 0.22 | -106.97 | 277.16 | -237.55 | -4.55 | |
| Foreign Exchange Rate Adjustments | -0.33 | -0.03 | -0.05 | - | - | |
| Net Cash Flow | 126.9 | -3.6 | -565.78 | 36.07 | 257.08 | |
| Free Cash Flow | 127.01 | 103.41 | 183.15 | 273.63 | 261.63 | |
| Free Cash Flow Growth | 22.82% | -43.54% | -33.06% | 4.58% | 56.67% | |
| Free Cash Flow Margin | 42.89% | 29.43% | 41.37% | 66.64% | 63.23% | |
| Free Cash Flow Per Share | 0.78 | 0.65 | 1.18 | 1.47 | 1.59 | |
| Cash Interest Paid | 30.33 | 32.56 | 13.55 | 5.75 | 7.22 | |
| Cash Income Tax Paid | 3.54 | 8.41 | 9.95 | 4.62 | 3.45 | |
| Levered Free Cash Flow | 111.57 | 80.31 | 204.13 | 161.46 | 170.05 | |
| Unlevered Free Cash Flow | 132.04 | 101.11 | 217.5 | 166.21 | 189.52 | |
| Change in Working Capital | 39.65 | -0.82 | 11.28 | 2.82 | 17.73 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.